BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25288799)

  • 1. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.
    Guarino C; Legowska M; Epinette C; Kellenberger C; Dallet-Choisy S; Sieńczyk M; Gabant G; Cadene M; Zoidakis J; Vlahou A; Wysocka M; Marchand-Adam S; Jenne DE; Lesner A; Gauthier F; Korkmaz B
    J Biol Chem; 2014 Nov; 289(46):31777-31791. PubMed ID: 25288799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the S4-S5 Specificity of Human Neutrophil Proteinase 3 to Improve the Potency of Peptidyl Di(chlorophenyl)-phosphonate Ester Inhibitors: A Kinetic and Molecular Modeling Analysis.
    Guarino C; Gruba N; Grzywa R; Dyguda-Kazimierowicz E; Hamon Y; Łȩgowska M; Skoreński M; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Jenne DE; Sieńczyk M; Lesner A; Gauthier F; Korkmaz B
    J Med Chem; 2018 Mar; 61(5):1858-1870. PubMed ID: 29442501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
    Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
    J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
    Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
    Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
    Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
    Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
    Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
    FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and use of highly specific substrates of neutrophil elastase and proteinase 3.
    Korkmaz B; Attucci S; Moreau T; Godat E; Juliano L; Gauthier F
    Am J Respir Cell Mol Biol; 2004 Jun; 30(6):801-7. PubMed ID: 14693667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase 3 phosphonic inhibitors.
    Grzywa R; Lesner A; Korkmaz B; Sieńczyk M
    Biochimie; 2019 Nov; 166():142-149. PubMed ID: 30876969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.
    Kantari C; Pederzoli-Ribeil M; Amir-Moazami O; Gausson-Dorey V; Moura IC; Lecomte MC; Benhamou M; Witko-Sarsat V
    Blood; 2007 Dec; 110(12):4086-95. PubMed ID: 17712045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
    Korkmaz B; Jenne DE; Gauthier F
    Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.
    Seren S; Rashed Abouzaid M; Eulenberg-Gustavus C; Hirschfeld J; Nasr Soliman H; Jerke U; N'Guessan K; Dallet-Choisy S; Lesner A; Lauritzen C; Schacher B; Eickholz P; Nagy N; Szell M; Croix C; Viaud-Massuard MC; Al Farraj Aldosari A; Ragunatha S; Ibrahim Mostafa M; Giampieri F; Battino M; Cornillier H; Lorette G; Stephan JL; Goizet C; Pedersen J; Gauthier F; Jenne DE; Marchand-Adam S; Chapple IL; Kettritz R; Korkmaz B
    J Biol Chem; 2018 Aug; 293(32):12415-12428. PubMed ID: 29925593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibitors of human neutrophil proteinase 3.
    Korkmaz B; Kellenberger C; Viaud-Massuard MC; Gauthier F
    Curr Pharm Des; 2013; 19(6):966-76. PubMed ID: 23016687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.
    Korkmaz B; Jaillet J; Jourdan ML; Gauthier A; Gauthier F; Attucci S
    J Biol Chem; 2009 Jul; 284(30):19896-902. PubMed ID: 19447886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).
    Korkmaz B; Lesner A; Letast S; Mahdi YK; Jourdan ML; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Viaud-Massuard MC; Jenne DE; Gauthier F
    Semin Immunopathol; 2013 Jul; 35(4):411-21. PubMed ID: 23385856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3.
    Budnjo A; Narawane S; Grauffel C; Schillinger AS; Fossen T; Reuter N; Haug BE
    J Med Chem; 2014 Nov; 57(22):9396-408. PubMed ID: 25365140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
    Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V
    J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
    Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
    J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2.
    Uehara A; Sugawara S; Muramoto K; Takada H
    J Immunol; 2002 Oct; 169(8):4594-603. PubMed ID: 12370398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles.
    Martin KR; Kantari-Mimoun C; Yin M; Pederzoli-Ribeil M; Angelot-Delettre F; Ceroi A; Grauffel C; Benhamou M; Reuter N; Saas P; Frachet P; Boulanger CM; Witko-Sarsat V
    J Biol Chem; 2016 May; 291(20):10476-89. PubMed ID: 26961880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils.
    Pederzoli M; Kantari C; Gausson V; Moriceau S; Witko-Sarsat V
    J Immunol; 2005 May; 174(10):6381-90. PubMed ID: 15879139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.